S1353 Pexact®: Analysis of 319 Procedures Performed at the Digestive Diseases Unit, University Hospital Aintree

Ahmed, Suhail; Bowering, Katherine; Polavarapu, Naveen; Nicholson, Roger; Thomas, Paul S.; Sturgess, Richard

doi:10.1016/s0016-5085(10)61069-4

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the eight retrospective series based around an index case of seeding, seeding was observed in 15 of 1742 patients with head and neck cancer (0.86%). In contrast, only two cases were identified in the randomized trial and the remaining prospective and retrospective series (2/3049; 0.07%). Combining both sets of data, the overall incidence of seeding in patients with head and neck cancer was 0.35% (17/4791) and 0.25% (1/397) in those with oesophageal cancer.…”

Section: Resultsmentioning

confidence: 94%

See 1 more Smart Citation

Tumor implantation following percutaneous endoscopic gastrostomy insertion for head and neck and oesophageal cancer: Review of the literature

Rowell

2019

Head & Neck

View full text Add to dashboard Cite

Background Because of publication bias, there is uncertainty about the true incidence of tumor seeding or implantation in patients with head and neck or oesophageal cancer undergoing percutaneous endoscopic gastrostomy (PEG) insertion. Methods In order to obtain a more reliable estimate of risk, a systematic review was undertaken. Randomized or non‐randomized studies and case reports were identified by electronic searching. A risk of bias assessment was carried out for each study. Results Ninety‐eight cases from 74 published case reports and 1 unpublished case were identified. Synchronous distant metastases were present in 37%. Analysis of case series (6192 patients) considered to carry a moderate risk of bias suggests an incidence of seeding after PEG insertion of 0.32%. Studies carrying a lower risk of bias indicate a risk of seeding closer to 1 in 2000. Conclusion The true risk of seeding after PEG insertion is probably less than 1 in 1000.

show abstract

Section: Resultsmentioning

confidence: 94%

“…Data from the randomized trial, the 27 retrospective and 2 prospective case series are summarized in Table .…”

Section: Resultsmentioning

confidence: 99%

Tumor implantation following percutaneous endoscopic gastrostomy insertion for head and neck and oesophageal cancer: Review of the literature

Rowell

2019

Head & Neck

View full text Add to dashboard Cite

show abstract

S1353 Pexact®: Analysis of 319 Procedures Performed at the Digestive Diseases Unit, University Hospital Aintree

Cited by 1 publication

References 0 publications

Tumor implantation following percutaneous endoscopic gastrostomy insertion for head and neck and oesophageal cancer: Review of the literature

Tumor implantation following percutaneous endoscopic gastrostomy insertion for head and neck and oesophageal cancer: Review of the literature

Contact Info

Product

Resources

About